Orion Genomics

NEW YORK (GenomeWeb News) – In a study appearing online today in Nature, researchers from the Malaysian Palm Oil Board, Orion Genomics, and elsewhere reported on findings from a genome and transcriptome sequencing study of

HandyLab (Becton Dickinson) has been awarded US Patent No. 8,088,616, "Heater unit for microfluidic diagnostic system."
Kalyan Handique is named as inventor on the patent.

By Ben Butkus
Orion Genomics said this week that it has non-exclusively licensed its MethylScreen technology to Qiagen for use in its EpiTect Methyl qPCR array kits for DNA methylation profiling and epigenetics studies.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Orion Genomics today said that it has licensed to Qiagen non-exclusive rights to its MethylScreen technology for epigenetics research.

People in the News

Premium

Jeff Fitzgerald has joined Expression Analysis as director of business development.

People in the News

Premium

Steven Smith has been selected to serve as the executive vice president of bioinformatics at Orion Genomics.

Roche, Toshiba, Sekisui Medical, Complete Genomics, Orion Genomics, JWCI, and Norchip are awarded US patents.

Sequenom, Aisin Seiki, Riken, University of California, Chinese University of Hong Kong, and Orion Genomics win US patents.

Orion Genomics and Novartis Molecular Diagnostics will use Orion's technologies to search for epigenetic markers related to a range of diseases.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.